PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Tilray Brands, Inc. (TLRY.TO)
2.000.05 (2.56%)
1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-0.07%
Revenue decline while Healthcare median is 0.00%. Seth Klarman would investigate if market share loss is temporary.
-34.65%
Cost reduction while Healthcare median is -0.01%. Seth Klarman would investigate competitive advantage potential.
822.03%
Growth of 822.03% versus flat Healthcare gross profit. Walter Schloss would verify quality.
822.56%
Margin change of 822.56% versus flat Healthcare margins. Walter Schloss would verify quality.
207.41%
R&D change of 207.41% versus flat Healthcare spending. Walter Schloss would verify adequacy.
-2.34%
G&A reduction while Healthcare median is 0.00%. Seth Klarman would investigate efficiency gains.
-17.12%
Marketing expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate competitive implications.
-21.03%
Other expenses reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
-11.69%
Operating expenses reduction while Healthcare median is -0.89%. Seth Klarman would investigate advantages.
-26.23%
Total costs reduction while Healthcare median is -2.44%. Seth Klarman would investigate advantages.
-74.43%
Interest expense reduction while Healthcare median is 0.00%. Seth Klarman would investigate advantages.
10.45%
D&A change of 10.45% versus flat Healthcare D&A. Walter Schloss would verify adequacy.
70.35%
EBITDA growth exceeding 1.5x Healthcare median of 1.41%. Joel Greenblatt would investigate advantages.
-99.75%
EBITDA margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-112.41%
Operating income decline while Healthcare median is 1.48%. Seth Klarman would investigate causes.
-112.42%
Operating margin decline while Healthcare median is 0.00%. Seth Klarman would investigate causes.
-608.08%
Other expenses reduction while Healthcare median is 13.69%. Seth Klarman would investigate advantages.
87.31%
Pre-tax income growth exceeding 1.5x Healthcare median of 4.81%. Joel Greenblatt would investigate advantages.
87.30%
Margin change of 87.30% versus flat Healthcare. Walter Schloss would verify quality.
289.61%
Tax expense change of 289.61% versus flat Healthcare. Walter Schloss would verify strategy.
85.63%
Net income growth exceeding 1.5x Healthcare median of 5.15%. Joel Greenblatt would investigate advantages.
85.62%
Margin change of 85.62% versus flat Healthcare. Walter Schloss would verify quality.
86.67%
EPS growth exceeding 1.5x Healthcare median of 7.50%. Joel Greenblatt would investigate advantages.
87.78%
Diluted EPS growth exceeding 1.5x Healthcare median of 7.69%. Joel Greenblatt would investigate advantages.
11.12%
Share count reduction below 50% of Healthcare median of 0.18%. Jim Chanos would check for issues.
13.10%
Diluted share reduction below 50% of Healthcare median of 0.16%. Jim Chanos would check for issues.